136 related articles for article (PubMed ID: 19016532)
21. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
[TBL] [Abstract][Full Text] [Related]
22. [Relation between changes of dendritic cell function and down-regulation of beta-centractin in hepatocellular carcinoma].
Weng YQ; Qiu SJ; Tang ZY; Gao Q; Wang KF; Song LJ; Ye SL; Liu YK; Fan J
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2050-3. PubMed ID: 17925177
[TBL] [Abstract][Full Text] [Related]
23. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis.
Zubaidah RM; Tan GS; Tan SB; Lim SG; Lin Q; Chung MC
Proteomics; 2008 Dec; 8(23-24):5086-96. PubMed ID: 19003864
[TBL] [Abstract][Full Text] [Related]
24. A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis.
Jia WD; Sun HC; Zhang JB; Xu Y; Qian YB; Pang JZ; Wang L; Qin LX; Liu YK; Tang ZY
Cancer Lett; 2007 Mar; 247(2):234-42. PubMed ID: 16806673
[TBL] [Abstract][Full Text] [Related]
25. A fully automated system with online sample loading, isotope dimethyl labeling and multidimensional separation for high-throughput quantitative proteome analysis.
Wang F; Chen R; Zhu J; Sun D; Song C; Wu Y; Ye M; Wang L; Zou H
Anal Chem; 2010 Apr; 82(7):3007-15. PubMed ID: 20230046
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen.
Lee HJ; Na K; Kwon MS; Kim H; Kim KS; Paik YK
Proteomics; 2009 Jun; 9(12):3395-408. PubMed ID: 19562805
[TBL] [Abstract][Full Text] [Related]
27. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
[TBL] [Abstract][Full Text] [Related]
30. Subcellular proteomics: determination of specific location and expression levels of lymphatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation.
Qazi AS; Sun M; Huang Y; Wei Y; Tang J
Biomed Pharmacother; 2011 Sep; 65(6):407-16. PubMed ID: 21741201
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
32. Comparative proteome analysis of three mouse lung adenocarcinoma CMT cell lines with different metastatic potential by two-dimensional gel electrophoresis and mass spectrometry.
Zhang K; Wrzesinski K; Stephen JF; Larsen PM; Zhang X; Roepstorff P
Proteomics; 2008 Dec; 8(23-24):4932-45. PubMed ID: 19003861
[TBL] [Abstract][Full Text] [Related]
33. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
[TBL] [Abstract][Full Text] [Related]
34. Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.
Lin YT; Chien KY; Wu CC; Chang WY; Chu LJ; Chen MC; Yeh CT; Yu JS
J Proteomics; 2017 Mar; 157():40-51. PubMed ID: 28192239
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of the Golgi proteome of hepatocellular carcinoma with that of the adjacent non-tumor tissues].
Xiao Z; Yi YF; He TT; Li YQ
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):23-6. PubMed ID: 20128964
[TBL] [Abstract][Full Text] [Related]
36. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
Wang FB; Rong Y; Fang M; Yuan JP; Peng CW; Liu SP; Li Y
Biomaterials; 2013 May; 34(15):3816-27. PubMed ID: 23465488
[TBL] [Abstract][Full Text] [Related]
37. Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
Lee YY; McKinney KQ; Ghosh S; Iannitti DA; Martinie JB; Caballes FR; Russo MW; Ahrens WA; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
J Proteome Res; 2011 Nov; 10(11):5070-83. PubMed ID: 21913717
[TBL] [Abstract][Full Text] [Related]
38. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
39. In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.
Li X; Jiang J; Zhao X; Zhao Y; Cao Q; Zhao Q; Han H; Wang J; Yu Z; Peng B; Ying W; Qian X
Oncotarget; 2016 Apr; 7(16):22031-49. PubMed ID: 27014972
[TBL] [Abstract][Full Text] [Related]
40. Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.
Chen RX; Song HY; Dong YY; Hu C; Zheng QD; Xue TC; Liu XH; Zhang Y; Chen J; Ren ZG; Liu YK; Cui JF
PLoS One; 2014; 9(3):e88543. PubMed ID: 24614035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
